system
sclerosi
ssc
system
lupu
erythematosu
sle
multisystem
autoimmun
disord
present
varieti
clinic
scenario
myocard
preval
sle
postmortem
studi
around
limit
scleroderma
lsc
diffus
scleroderma
also
carri
differ
prognost
signifi
canc
two
condit
fi
rst
two
present
initi
indistinguish
acut
coronari
syndrom
particularli
second
treat
st
segment
elev
myocardi
infarct
stemi
thrombolysi
earli
coronari
angiographi
exclud
possibl
lead
diagnosi
myocard
like
due
sle
howev
failur
respons
treatment
led
consider
altern
aetiolog
reli
multipl
diagnost
modal
includ
endomyocardi
biopsi
emb
cardiac
mri
cmri
coupl
recognit
rare
clinic
sign
case
also
highlight
signifi
canc
collabor
team
differ
specialti
led
posit
outcom
asian
gentleman
present
local
district
gener
hospit
histori
gener
malais
rigor
atyp
chest
pain
dyspnoea
medic
histori
includ
sle
joint
renal
involv
renal
biopsi
demonstr
type
iiiiv
v
nephriti
respect
two
month
prior
present
discontinu
lupu
treatment
consist
mycophenol
mofetil
mmf
prednisolon
lifelong
nonsmok
famili
histori
ischaem
heart
diseas
admiss
vital
sign
normal
physic
examin
demonstr
third
heart
sound
gallop
rhythm
multipl
striae
thigh
like
secondari
long
term
steroid
importantli
note
linear
scar
frontopariet
region
appear
indur
alopec
fi
gure
strongli
resembl
scleroderma
en
coup
de
sabr
histolog
examin
perform
lesion
ecg
demonstr
inferolater
st
segment
elev
fi
gure
laboratori
test
reveal
troponin
peak
creatin
kinas
c
reactiv
protein
erythrocyt
sediment
rate
derang
liver
function
test
lft
chest
xray
cxr
unremark
transthorac
echocardiographi
tte
demonstr
moder
concentr
lv
hypertrophi
lvh
normal
lv
size
borderlin
reduc
lv
eject
fraction
lvef
mark
inferoposterior
hypokinesia
increas
subendocardi
echodens
left
heart
catheteris
show
unobstruct
coronari
arteri
stage
conclus
region
myocard
secondari
sle
therefor
reintroduc
mmf
prednisolon
gradual
clinic
improv
partial
normalis
laboratori
test
result
two
month
later
readmit
similar
acut
present
inferior
st
segment
elev
new
anterior
biphas
wave
chang
ecg
thrombolys
tenectaplas
suspect
inferior
stemi
tte
identifi
ed
new
sever
anterosept
apic
hypokinesia
mild
posterior
hypokinesia
mildli
reduc
lv
function
routin
laboratori
test
confi
rmed
acut
infl
ammatori
respons
flare
sle
myocard
suspect
treat
intraven
methylprednisolon
readmit
outpati
visit
progress
exert
breathless
system
symptom
ecg
demonstr
anterior
wave
chang
st
segment
elev
routin
blood
test
reveal
mild
microcyt
anaemia
mildli
elev
infl
ammatori
marker
worsen
lft
troponin
unusu
associ
diseasessymptom
sle
recurr
heart
failur
dermatolog
clue
anoth
ad
possibl
man
system
lupu
erythematosu
sle
present
chest
pain
inferolater
st
segment
elev
ecg
elev
cardiac
biomark
infl
ammatori
marker
coronari
angiographi
rule
obstruct
coronari
arteri
diseas
cad
echocardiographi
show
impair
region
global
left
ventricular
lv
function
treat
sle
myocard
institut
aggress
immunosuppress
therapi
partial
improv
condit
follow
relaps
remit
cours
subsequ
month
progress
impair
lv
function
cardiac
mri
show
activ
infl
ammat
extens
transmur
scar
endomyocardi
biopsi
emb
demonstr
patchi
myocardi
fi
brosi
lowgrad
myocard
pcr
assay
exclud
viral
caus
lack
respons
immunosuppress
detect
sign
en
coup
de
sabr
suggest
scleroderma
underli
caus
myocard
mildli
elev
remain
throughout
admiss
although
fl
uctuat
consist
activ
myocard
cxr
demonstr
congest
cardiac
failur
tte
reveal
sever
global
lv
impair
lvef
underw
extens
investig
includ
ventilationperfus
scan
high
resolut
ct
ct
chest
abdomen
pelvi
positron
emiss
tomographi
scan
liver
biliari
tract
mri
oesophagogastroduodenoscopi
colonoscopi
bone
marrow
biopsi
fail
demonstr
underli
patholog
patient
clinic
present
result
initi
laboratori
imag
investig
strongli
suggest
myocard
perform
extens
autoimmun
screen
demonstr
neg
dsdna
ena
weakli
posit
ana
normal
reduc
posit
panca
neg
antimpo
smooth
muscl
antibodi
ab
liverkidneymicrosom
ab
histopatholog
could
distinguish
sle
ssc
caus
myocardit
process
lack
respons
lupu
immunosuppress
therapi
like
presenc
scleroderma
en
coup
de
sabr
culmin
consider
scleroderma
possibl
caus
myocardit
process
patient
sle
differenti
diagnosi
chest
pain
st
segment
elev
ecg
includ
myocardi
infarct
due
thrombot
coronari
fi
rst
admiss
patient
initi
treat
possibl
nstemi
follow
reassur
result
coronari
angiographi
receiv
immunosuppress
therapi
mmf
prednisolon
second
present
acut
consid
secondari
inferior
stemi
underw
thrombolysi
treat
intraven
methylprednisolon
inpati
cyclophosphamid
warfarin
outpati
follow
detect
lupu
anticoagul
factor
serum
third
admiss
receiv
treatment
congest
heart
failur
discharg
prolong
hospitalis
institut
appropri
immunosuppress
treatment
introduct
appropri
immunosuppress
medic
therapi
heart
failur
patient
discharg
regularli
assess
outpati
depart
pleas
learn
success
complet
cardiac
rehabilit
programm
progress
improv
exercis
toler
current
new
york
heart
associ
nyha
recent
tte
demonstr
moder
lv
dysfunct
hypokinesia
midap
septum
inferior
posterior
wall
coronari
arteri
diseas
cad
sle
preval
time
higher
control
agarw
et
al
demonstr
risk
myocardi
infarct
sle
women
greater
time
match
healthi
women
differ
mechan
play
role
develop
cad
sle
includ
prematur
atherosclerosi
coronari
arter
thrombot
event
without
antiphospholipid
antibodi
vasospasm
embolis
valvular
materi
hypertens
coronari
angiographi
perform
patient
exclud
atherosclerot
cad
stage
histori
diagnost
fi
nding
suggest
possibl
sle
myocard
cardiac
involv
preval
sle
postmortem
studi
much
less
commonli
diagnos
clinic
affect
pericardium
endocardium
myocardium
coronari
arteri
conduct
tissu
pulerwitz
colleagu
retrospect
examin
patient
histolog
diagnosi
myocard
emb
accord
dalla
criteria
conclud
overal
prognosi
secondari
myocard
wors
primari
myocard
importantli
former
clearli
infl
uenc
underli
condit
good
prognosi
peripartum
myocard
poor
prognosi
hiv
myocard
trend
toward
wors
prognosi
myocard
associ
ctd
leyngold
colleagu
evalu
patient
unexplain
cardiomyopathi
underw
emb
identifi
ed
total
patient
ctd
initi
unexplain
cardiomyopathi
base
dalla
criteria
confi
rmed
signifi
cantli
lower
surviv
rate
undifferenti
ctd
adjust
hr
death
ci
p
trend
toward
decreas
surviv
patient
ssc
compar
idopath
dilat
cardiomyopathi
dcm
adjust
hr
death
ci
p
signifi
cant
prognost
differ
observ
sle
idiopath
dcm
adjust
hr
death
ci
p
interestingli
statist
signifi
cant
surviv
differ
observ
patient
cardiomyopathi
ctd
without
myocard
adjust
hr
death
ci
p
patient
histolog
fi
nding
suggest
lowgrad
myocard
secondari
viral
infect
system
infl
ammatori
diseas
associ
sle
scleroderma
pcr
assay
emb
sampl
rule
viral
caus
scleroderma
heart
diseas
classifi
ed
primari
pericardi
effus
coronari
vasospasm
myocard
coronari
vascul
interstiti
fi
brosi
secondari
due
pulmonari
involv
right
heart
failur
due
pulmonari
fi
brosi
pulmonari
vascul
renal
diseas
system
hypertens
cardiac
involv
appear
less
frequent
limit
cutan
ssc
diffus
cutan
ssc
myocardi
fi
brosi
hallmark
establish
myocardi
involv
ssc
fibrot
lesion
patchi
distribut
ventricl
thought
follow
repeat
focal
ischaemia
caus
abnorm
vasoreact
without
associ
structur
vascular
diseas
patient
present
linear
scar
forehead
strongli
suggest
scleroderma
en
coup
de
sabr
rare
form
lsc
typic
affect
skin
one
half
face
scalp
slow
progress
cours
linear
scleroderma
repres
case
lsc
common
variant
seen
children
zulian
et
al
conduct
larg
multin
studi
patient
demonstr
popul
lsc
primarili
linear
variant
extracutan
diseas
includ
articular
neurolog
vascular
ocular
gastrointestin
respiratori
cardiac
renal
involv
interestingli
within
clinicopatholog
spectrum
cutan
lupu
erythematosu
lupu
erythematosu
pannicul
repres
uncommon
variant
characteris
erythemat
fl
eshcolour
deep
nodul
predilect
upper
limb
face
could
also
although
rare
manifest
linear
confi
gurat
reseml
scleroderma
en
coup
de
sabr
case
histolog
examin
distinguish
two
condit
importantli
coexist
featur
chronic
cutan
lupu
erythematosu
scleroderma
skin
lesion
report
case
name
sclerodermiform
linear
lupu
erythematosu
suggest
disord
biopsi
lesion
perform
although
clinic
bandlik
scar
resembl
scleroderma
en
coup
de
sabr
histolog
examin
could
confi
rmed
diagnosi
combin
clinic
present
laboratori
imag
invas
investig
lack
respons
aggress
immunosuppress
therapi
led
consider
scleroderma
myocard
possibl
diagnosi
knowledg
would
fi
rst
case
scleroderma
myocard
en
coup
de
sabr
patient
sle
learn
point
diagnosi
made
possibl
close
collabor
cardiolog
rheumatolog
radiolog
histopatholog
team
therefor
good
exampl
multidisciplinari
work
led
rare
diagnosi
complex
patient
case
highlight
valu
cmri
emb
especi
clinic
featur
fi
initi
diagnosi
physician
wari
attribut
new
symptom
progress
primari
condit
without
consid
altern
disord
